Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Market Cap	21.57B
Revenue (ttm)	2.00B
Net Income (ttm)	716.94M
Shares Out	54.46M
EPS (ttm)	13.15
PE Ratio	30.11
Forward PE	n/a
Dividend	11.60 (2.93%)
Ex-Dividend Date	Aug 4, 2025

Volume	11,143
Average Volume	11,814
Open	404.00
Previous Close	399.50
Day's Range	396.00 - 404.00
52-Week Range	271.00 - 501.00
Beta	-0.07
RSI	52.58
Earnings Date	Mar 16, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4728

Financial Performance

In 2024, Sunmax Biotechnology's revenue was 1.82 billion, an increase of 7.64% compared to the previous year's 1.69 billion. Earnings were 679.41 million, an increase of 8.58%.